IraS.WollnerMD

Oncology • Detroit, MI

Gastrointestinal Cancer

Associate Division Head, Division of Hematology/Oncology

Join to view full profile

Dr. Wollner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wollner's full profile

Already have an account?

Office
2799 West Grand Boulevard
CFP 579
Detroit, MI 48202
Phone+1 313-916-1332

Fax+1 313-916-7911
Is this information wrong?

Education & Training

University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Michigan Health SystemFellowship, Geriatric Medicine (Internal Medicine), 1982 - 1983
University of Michigan Health SystemResidency, Internal Medicine, 1979 - 1982
Rutgers New Jersey Medical SchoolClass of 1979

Certifications & Licensure

MI State Medical License 1980 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
Terminated
Phase 3
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

49 citations
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
Julie R Brahmer, Charles G Drake, Ira Wollner, John D Powderly, Joel Picus, William H Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M Salay, Tracee L McMiller, M...> ;Journal of Clinical Oncology. 2023 Feb 1
8 citations
Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Kannan Thanikachalam, Trevor Seixas, Irina Dobrosotskaya, Ira Wollner, David Kwon, Kenneth Winters, Mohammad Raoufi, Jia Li, Farzan Siddiqui, Gazala N. Khan, Vijay Dam...> ;American Journal of Clinical Oncology. 2020 Jun 1
50 citations
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists
Susan Eggly, Lauren M. Hamel, Tanina Foster, Terrance L. Albrecht, Robert Chapman, Felicity W. K. Harper, Hayley S. Thompson, Jennifer J. Griggs, Richard Gonzalez, Lis...> ;Patient Education and Counseling. 2017 May 1
Germ cell tumour of the trachea.
Steven Gamalski, Javier Munoz, Alicia Diaz-Kuan, Ira Wollner> ;BMJ Case Reports. 2012 Jul 6
9 citations
Quality of life and performance status in patients with pancreatic and periampullary tumors.
Vic Velanovich, Ira Wollner> ;International Journal of Clinical Oncology. 2011 Feb 24
6 citations
Sorafenib induced radiation recall dermatitis after spine radiosurgery.
Jared R. Robbins, Ira Wollner, Samuel Ryu> ;Journal of Radiosurgery and SBRT. 2011 Jan 1
87 citations
Vascular endothelial growth factor in the management of hepatocellular carcinoma: A review of literature
Ahmed Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip> ;Cancer. 2009 Nov 1
11 citations
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
Joanna M. Brell, Smitha S. Krishnamurthi, Milind Javle, Joel N. Saltzman, Ira Wollner, Robert Pelley, Afshin Dowlati, Belagodu N. Kantharaj, Mark D. Schluchter, Linda ...> ;Cancer Chemotherapy and Pharmacology. 2009 Apr 1
5 citations
Fatal hypersensitivity reaction to gemtuzumab ozogamicin associated with platelet transfusion
Amr Hanbali, Ira Wollner, Klodiana Neme, Cynthia Ulreich> ;American Journal of Health-System Pharmacy. 2007 Jul 1
27 citations
Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies.
Vic Velanovich, Ira Wollner, Munther Ajlouni> ;Journal of Gastrointestinal Surgery. 2000 Sep 1
14 citations
Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
J. A. Carr, Munther Ajlouni, Ira Wollner, D. Wong, Vic Velanovich> ;The American Surgeon. 1999 Dec 1
14 citations
Disappearance of factor VIII antibody after removal of primary colon adenocarcinoma.
Muhammad Shurafa, S. Raman, Ira Wollner> ;American Journal of Hematology. 1995 Oct 1
3 citations
Floxuridine-associated sclerosing cholangitis. A dog model.
James C. Andrews, James A. Knol, Ira S. Wollner, Conrad A. Knutsen, Patricia K. Smith, Diane M. Prieskorn, William D. Ensminger> ;Investigative Radiology. 1989 Jan 1
2 citations
Combination chemo-radiation therapy for jaundice due to focal malignant obstruction of the major bile ducts.
Ira S. Wollner, Robert M. Prust, James C. Andrews, Suzette C. Walker-Andrews, Timothy T. Nostrant, James A. Knol, Frederic E. Eckhauser, Kyung J. Cho, Allen S. Lichter...> ;Selective Cancer Therapeutics. 1989 Jan 1
10 citations
Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Philip L. Stetson, Jonathan Maybaum, John G. Wagner, Damon R. Averill, Ira S. Wollner, James A. Knol, Norma J. Johnson, Zhaomin Yang, Diane Preiskorn, Patricia K. Smit...> ;Cancer Research. 1988 Dec 1
19 citations
Localization and Imaging of Radiolabeled Monoclonal Antibodies against Colorectal Carcinoma in Tumor-bearing Nude Mice
Donald J. Buchsbaum, Ricardo V. Lloyd, Jack E. Juni, Ira S. Wollner, Pamela G. Brubaker, D.E. Hanna, Judith Spicker, Felissa Burns, Zenon Steplewski, David Colcher, Je...> ;Cancer Research. 1988 Aug 1
Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.
Amnon Shapira, John G. Wagner, Ira S. Wollner, Jonathan Maybaum, Phillip L. Stetson, William D. Ensminger, Thomas E. Carey> ;Pharmaceutical Research. 1988 Aug 1
64 citations
Effects of hepatic arterial yttrium 90 glass microspheres in dogs.
Ira S. Wollner, Conrad A. Knutsen, Patricia K. Smith, Diane M. Prieskorn, Clarence E. Chrisp, James C. Andrews, Jack E. Juni, Sara L. Warber, Joyce Kleveringm, James W...> ;Cancer. 1988 Apr 1
27 citations
Effects of Hepatic Arterial Yttrium-90 Microsphere Administration Alone and Combined with Regional Bromodeoxyuridine Infusion in Dogs
Ira S. Wollner, Conrad A. Knutsen, Kathleen A. Ullrich, Clarence E. Chrisp, Jack E. Juni, James C. Andrews, Michael J. Tuscan, Philip L. Stetson, William D. Ensminger> ;Cancer Research. 1987 Jun 15
4 citations
A Dog Model Using an implanted System for Protracted Hepatic Arterial Chemotherapy
Ira S. Wollner, Conrad A. Knutsen, K. A. Ullrich, John E. Niederhuber, James W. Crudup, Jack E. Juni, Sara L. Warber, John W. Gyves, Phillip L. Stetson, William D. Ens...> ;The Journal of Surgical Research. 1986 Nov 1
78 citations
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
John G. Wagner, John W. Gyves, Philip L. Stetson, Suzette C. Walker-Andrews, Ira S. Wollner, Michael K. Cochran, William D. Ensminger> ;Cancer Research. 1986 Mar 1
16 citations
Phase II study of hepatic arterial degradable starch microspheres and mitomycin.
Ira S. Wollner, Suzette C. Walker-Andrews, Johl E. Smith, William D. Ensminger> ;Cancer Drug Delivery. 1986 Jan 1
Join now to see all